Clinical Trial Update: Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes

View source ↗

Summary

A completed trial compared nighttime administration and hypoglycemia risk between insulin glargine and NPH insulin in people with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• NPH insulin (insulin isophane)

Snippet

Sponsor: University of Giessen | Conditions: Diabetes | Status: COMPLETED